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1. Introduction 
Cardiac complications are the most common complications in patients with infective 
endocarditis, and they can be related to significant mortality and morbidity. (1) Extra-
cardiac manifestations along with their historical descriptions such as splinter hemorrhages, 
emboli, Osler’s nodes, Janeway and Bowman lesions of the eye, Roth’s spots, patechiae and 
clubbing generally result from thromboemboli or septic emboli. (2) Inflammatory 
complications may occur as a result of septic emboli, and these include endogenous 
(metastatic) endophthalmitis, focal abscess, and vasculitis. (3) In this chapter we mainly 
focus on the endogenous endophthalmitis arising as a complication of infective 
endocarditis.  
Endogenous (metastatic) endophthalmitis is an inflammatory condition of the intraocular 
structures including the aqueous, iris, lens, ciliary body, vitreous, choroid and retina. (4-6) It 
results from the hematogenous spread of organisms from a distant source of infection, most 
commonly infective endocarditis, gastrointestinal tract and urinary tract infections and 
wound infections. (7-9) Other sources of infection have included pharyngitis, pneumonia, 
septic arthritis and meningitis. (10,11) Compared with endophthalmitis following trauma or 
surgery, endogenous endophthalmitis is relatively rare, accounting 2-8% of all reported 
endophthalmitis cases. (5) However, endogenous endophthalmitis carries with it the danger 
of bilateral infection in 15-25% of cases. (6,12) 
2. Epidemiology 
Endogenous endophthalmitis has been reported to occur at any age and no sexual 
predilection. (13) However, in the recent years the mean age of endogenous endophthalmitis 
has shifted to 65 years possibly because of the reduction in the incidence of rheumatic heart 
disease. (14) 
The mean incidence of endogenous endophthalmitis was reported as1.8 cases/year, and 
48.1% of patients presented were seen as outpatients. (15) Endogenous bacterial 
endophthalmitis is recognized as a major cause of visual loss with an associated high 
mortality rate. (16,17) It is considered a diagnostic challenge in the early stages of the 
disease, with 16% to 63% of cases being initially misdiagnosed (18). In unilateral cases, the 
right eye is twice as likely to become infected as the left eye, probably because of the more 
proximal location and direct blood flow to the right carotid artery. (19) 
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3. Classification of endogenous endophthalmitis 
A classification system introduced by Greenwald et al. takes into consideration the affected 
areas of the globe and the associated visual prognosis. (20) It is divided as focal anterior or 
posterior, diffuse anterior or posterior and panophthalmitis. (20) Anterior focal 
endophthalmitis manifests as localized inflammatory nodules or plaques in the iris and /or 
ciliary body associated with iridocyclitis and minimal hypopyon. (5,21) (Fig. 1) Intraocular 
pressure varies from normal to high. (5,21) The anterior vitreous has no or minimal 
inflammation. (5,21) The retina is normal. (5,21) The prognosis in these cases is good. (21) 
Anterior diffuse endophthalmitis is characterized by a more severe anterior segment 
inflammation associated with conjunctival chemosis, marked anterior chamber reaction with 
fibrin clots and significant hypopyon that hampers the view of retina. (5,21) (Fig. 2)  
 
Fig. 1. Anterior focal endophthalmitis presented with an inflammatory nodule in the iris 
extending from the ciliary body 
 
Fig. 2. Anterior diffuse endophthalmitis with a more severe anterior segment inflammation 
associated with conjunctival chemosis, marked anterior chamber reaction with fibrin clots 
and significant hypopyon 
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Fig. 3. Anterior diffuse endophthalmitis with posterior synechia and corneal haze 
Intraocular pressure is typically elevated. (22) Corneal opacification may occur. (22) (Fig. 3)  
It is an ocular emergency and if not promptly and adequately treated the infection can 
spread to the entire eye. (22) The visual prognosis is excellent with aggressive and 
appropriate treatment. Blindness usually results from delay in treatment. (22) Posterior focal 
endophthalmitis manifests as white-yellowish retinal or choroidal lesions associated with 
retinal hemorrhages and vitreous cells and/or debris. (23) (Fig. 4) Infections caused by 
Gram-positive organisms may show multifocal lesions. (23) However, Gram-negative 
infections usually cause a single large choroidal abscess involving the posterior pole. (24,25) 
(Fig. 5) The anterior chamber reaction is usually mild with or without keratic precipitates. 
(23) (Fig. 6) The intraocular pressure varies from low to normal. (23) Posterior diffuse 
endophthalmitis may present as multiple whitish lesions located inside the vessels or in the  
 
Fig. 4. Posterior focal endophthalmitis manifested as white-yellowish retinal or choroidal 
lesions associated with vitreous cells and/or debris 
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Fig. 5. A single large choroidal abscess involving the posterior pole 
 
Fig. 6. Mild anterior chamber reaction with keratic precipitates 
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retina with perivascular hemorrhages in the early stages of the disease. (26) As the infection 
progresses, the retina becomes necrotic, and vitreous abscess frequently occur. (26) (Fig. 7) 
The anterior segment is also involved with forward spread of the infection and hypopyon is 
formed as the disease progresses. (26) (Fig. 8) The intraocular pressure is low. (26) The poor 
visual prognosis is most likely due to retinal ischemia as a result of occlusion of central 
retinal artery by a septic embolus. (26) Panophthalmitis is inflammation of all coats of the 
eye including intraocular structures. (27-29) It presents with marked lid edema, proptosis 
and limitation of ocular movements. (28) (Fig. 9) All details of anterior as well as posterior 
chamber are lost because of the prominent hypopyon. (29) (Fig. 10) Typically the intraocular 
pressure is high. (29)It is a disastrous and rapidly developing infection that destroys the 
globe and invades the orbit, resulting in blindness, phthisis or enucleation. (28,29) 
Depending of the virulence of pathogen, progression of panophthalmitis may be life 
threatening. (28) 
 
Fig. 7. Necrotic / hemorrhagic retina with vitreous abscess 
 
Fig. 8. Forward spread of infection with hypopyon formation 
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Fig. 9. Panophthalmitis with marked lid edema and proptosis 
 
Fig. 10. Severe panophthalmitis with loss of the details of anterior and posterior segments of 
the eye 
4. Pathogenesis 
In endogenous endophthalmitis the microorganisms enter into the uveal tract or retinal 
circulation as scattered organisms or in a bolus, and lodge in small capillaries. (30,31) To 
invade ocular tissues and produce infection the organisms must cross the blood-ocular 
barrier either by direct invasion (septic emboli) or by changes in vascular endothelium 
caused by substrates released during infection. (30) They establish a septic focus that can 
develop in the retina prior to breaking into the vitreous. (30) The infectious embolus is 
usually in proximity to the retinal vessels. (30) If a large septic embolus pass through the 
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central retinal artery and disseminates throughout the retina, retinal necrosis and ischemia 
may occur. (30) This allows the microorganisms to quickly invade the vitreous and further 
the anterior segment, causing inflammation of intraocular tissues (panuveitis) that may be 
mixed-up a non-infectious inflammatory disease. (31) Similarly, in cases of fungal 
endophthalmitis a localized inflammatory reaction surrounding a small nidus of fungi 
forms in the inner choroid, breaks through Bruch’s membrane into the retina forming a 
microabscess and spreads into the vitreous cavity. (31) It is a destructive process that has a 
poor visual prognosis that the visual loss rate reaches up to 37.5%. (30) The final visual 
outcome in patients with endogenous bacterial endophthalmitis in the recent 12 years has 
not differed significantly from five decades ago. (31) Under normal circumstances, the 
blood-ocular barrier provides a natural resistance against invading organisms. (30) 
Destruction of intraocular tissues may be due to direct invasion of the organism and/or 
from inflammatory mediators of the immune system. (30,31) In any type of endophthalmitis, 
bacteria are introduced into the intraocular environment, encountering a site of 
immunological inactivity. (30) The intraocular environment is termed an “immune 
privileged site”, devoid of inflammatory mediators and cells present that would otherwise 
fight infection. (32) The blood-ocular barrier facilitates maintenance of a sterile environment 
in the interior of the eye contributing to the immune privileged site. (32) In this environment 
initial immune responses that would typically handle infection are delayed or absent, 
providing an optimum growth medium for the organisms that reach the area. (32) 
Eventually, organisms are recognized and inflammation initiates in an effort to handle the 
infection. (30) The extent of inflammation in the eye is during endophthalmitis has been 
shown to be organism dependent. (30,31) The course of endophthalmitis, treatment 
effectiveness and visual outcome can be unpredictable. (33) Clinical presentation of the 
disease depends, in part, on the relative virulence of the infecting pathogen, the mechanism 
of introduction into the eye and how quickly treatment is initiated. (33) Other factors that 
affect the outcome of infection include the patients’ age, how vulnerable the infecting agent 
is to antibiotic therapy and the anatomic condition of the eye during infection. (33) Clinical 
studies have reported that increased time between infection and treatment is associated with 
a worse visual outcome. (19,34) Endophthalmitis may be as subtle as white nodules on the 
lens capsule, iris, retina, or choroid. (35) It can also be as ubiquitous as inflammation of all 
the ocular tissues, leading to a globe full of purulent exudate. (36) In addition, inflammation 
can spread to involve the orbital soft tissue. (37) 
5. Mortality/morbidity 
Decreased vision and permanent loss of vision are common complications of 
endophthalmitis. (33,34) Patients may require enucleation to eradicate a blind and painful 
eye. (38) Mortality is related to the patient’s comorbidities and the underlying medical 
problem, especially when considering the etiology of hematogenous spread in endogenous 
infections. (39,40) 
6. Clinical presentations 
Bacterial endophthalmitis usually presents acutely with pain, redness, lid swelling, and 
decreased visual acuity. (11,16,22) Specific signs have been described which may suggest a 
specific infecting organism. For example, Bacillus infections characteristically demonstrate  
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chocolate brown anterior chamber exudates with a ring-shaped white corneal infiltrate. (41) 
Serratia infections may be associated with a pink or dark hypopyon. (42,43) An eye with 
Klebsiella or Group B Streptoccoccus endogenous endophthalmitis often has a pupillary 
hypopyon. (44,45) The hypopyon associated with Group B Streptococcus often does not 
organize and shifts to occupy the most dependent portion of the anterior chamber. This has 
been termed a “sliding hypopyon”. (46) Fungal endophthalmitis may present with an 
indolent course over days to weeks. (47) Symptoms are often blurred vision, pain and 
decreased visual acuity. (47) Individuals with candidal infection may present with high 
fever, followed several days later by ocular symptoms. (48) Persistent fever of unknown 
origin may be associated with an occult retinochoroidal fungal infiltrate. (48) A 
characteristic sign of endogenous Candida endophthalmitis is a creamy, white, well-
circumscribed lesion, involving the retina and choroid in the posterior pole. (48) Aspergillus 
endogenous endophthalmitis, although less common, is frequently a more fulminant disease. 
(40) Nearly all patients have anterior chamber cells and keratic precipitates. (40) The 
inflammation may result in hypopyon, pupillary membrane, rubeosis iridis, and an anterior 
chamber inflammatory mass. (40) Posteriorly, chorioretinitis may appear as fluffy yellow-
white elevated chorioretinal opacities. (49) Gravitational layering of the inflammatory cells 
may produce a subhyaloid or subretinal “hypopyon” especially since subretinal and 
subretinal pigment epithelial infection tends to occur with Aspergillus. (49) Retinal 
detachment mat complicate the infection. ( 40) Retinal haemorrhages and perivasculitis may 
be present. (40) Ultimately full thickness retinal necrosis may occur. (40) The earlier signs of 
endogenous endophthalmitis include Roth’s spot (round, white retinal spots surrounded by 
hemorrhage) (Fig. 11), hemorrhagic spots in the conjunctiva, superficial or profound retinal 
hemorrhage, and retinal periphlebitis. (20-22) The occlusion of small arterioles may produce 
cotton-wool spots, or if the larger vessels are involved, branch retinal or central retinal 
artery obstruction. (20-22) Slit-lamp examination reveales ciliary injection, keratic 
precipitates (KP), mild to moderate cells and flare in the anterior chamber or severe iritis 
with hypopyon formation and fibrin precipitates. (21,22) Ophthalmoscopy shows 
infiltrations of the retina and vitreous, retinal vasculitis and retinal hemorrhage or dense 
vitreous opacities progressing to white mass obstructing fundus view. (26,27) If the fundus  
 
Fig. 11. Roth Spots characterized by round, white retinal spots surrounded by hemorrhage 
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view is obscured, imaging with optical coherence tomography, ocular ultrasonography, 
electroretinogram tests are useful in displaying the extent of vitreous involvement, 
choroidal abscesses, retinal detachment and scleral thickening. (16,18,22) Computed 
tomography scans allow high resolution orbital imaging in cases of suspected 
panophthalmitis to detect abscess formation or confirm the presence of contiguous orbital 
involvement. (37) 
7. Causes 
Individuals at risk for developing endogenous endophthalmitis usually have comorbidities 
that predispose them to infection. These include conditions like diabetes mellitus, chronic 
renal failure, cardiac valvular disorders, prosthetic heart valves, systemic lupus 
erythematosus, AIDS, leukemia, gastrointestinal malignancies, neutropenia, lymphoma, 
alcoholic hepatitis, intravenous drug abuse, and bone marrow transplantation. (50,51) 
Sources of endophthalmitis include most commonly endocarditis followed by urinary tract 
infection, wound infection and meningitis. (4) Additionally, pharyngitis, pulmonary 
infection, septic arthritis, pyelonephritis and intraabdominal abscess have also been 
implicated as sources of infection. (10) About 25% of the cases are bilateral and usually 
caused by Meningococcus, E.coli and Klebsiella species. (52,53) The most common cause in 
two-thirds of the infections is Gram-positive bacteria. (31,33) Although the most common 
agent was S.aureus (25% of patients), the most common group was streptococcus (32%). 
(31,33) Endogenous endophthalmitis in adults caused by group B Streptococcus has been 
reported rarely and is almost exclusively related to infective endocarditis. (7,54) Gram-
negative organisms cause 32-37% of all endogenous endophthalmitis cases and typically 
have poor visual outcomes because these infections are difficult to treat. (5,55,56) The low 
prevalence of Gram-negative bacteria amongst the causative organisms of both infective 
endocarditis and endogenous endophthalmitis might be related to the absence of an outer 
capsule, which makes them sensitive to complement mediated lysis and other humoral 
innate immune defenses, and the lack of surface proteins that specifically bind host matrix 
molecules and prosthetic material. (57) Moreover, a much higher inoculums of Gram-
negative than Gram-positive organisms is required to induce infective endocarditis in 
laboratory animals. (57) Although aggressive therapy was given, the visual prognosis for all 
these patients was poor. (56,57) E. coli emphysematous endophthalmitis is a very rare and 
severe variety of E. coli endophthalmitis. (58,59) The mechanism of emphysematous 
endophthalmitis has been postulated that a high concentration of glucose in the eye tissue 
may provide a substrate that bacteria can ferment to produce carbondioxide and hydrogen. 
(58) A computerized tomography scan of the orbits demonstrate gas bubble in the eye globe 
indicating emphysematous endophthalmitis. (59) Extra-intestinal pathogenic E.coli (ExPEC) 
are able to colonize tissue outside the gastrointestinal tract and contain a variety of virulence 
factors that may enable the pathogens to invade and induce infections in the cardiac 
endothelia. (57,60) These cases are further complicated by spondylodiscitis and bilateral 
endophthalmitis. (60) Endogenous endophthalmitis is usually associated with Gram-negative 
bacteria, most commonly Klebsiella pneumonia (77.4%) among the East Asian population. 
(6,61,62) The patients at highest risk are diabetic patients with hepatobiliary infections. (6,61) 
Klebsiella pneumonia endogenous endophthalmitis is a severe but potentially subclinical 
disease. (62) Early diagnosis requires a high index of suspicion and recognition of risk 
factors including Asian ancestry and other sources of systemic infection including most 
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commonly liver abscess. (6,61) In contrast, in the Caucasian population, Gram-positive cocci 
including Staphylococcus aureus, Streptococcus pneumonia and other streptococcal species 
are the most common causes of bacterial endogenous endophthalmitis. (31,33) Septic 
metastasis to the iris is a rare manifestation of endogenous endophthalmitis presented with 
acute painful red eye, hypopyon and iris abscess that might be caused by S.aureus. (63) 
Subacute bacterial endocarditis caused by viridians streptococci is characterized by a 
lingering start of the disease with high temperature of unknown origin and an unspecific 
feeling of illness. (64,65) The ophthalmological findings can manifest itself before the 
diagnosis of the underlying disease is made. (65) Complications such as blindness after 
fulminant endophthalmitis and death can be avoided through quick diagnosis and treatment. 
(64,65) Group B Streptococcus endogenous endophthalmitis is a devastating condition with 
poor visual prognosis despite therapy. (66,67) It is a rare condition that 17 cases have been 
reported since 1985. (7) Group B Streptococcus endogenous endophthalmitis was found to 
arise from hematogenous spread from endocarditis at a rate of 33.3%. (7) Increasing 
incidence of invasive Group B Streptococcus infection with its varying manifestations 
including metastatic endophthalmitis has been reported recently in adults with 
predisposing illnesses. (54,68) Streptococcus anginosus is a member of Streptococcus milleri 
group and is a commensal found in the mouth, nasopharnyx, throat and sinuses. (69) It is 
associated with infective endocarditis with a longer than average duration of evolution 
before diagnosis. (70) S. anginosus should also be considered in the differential diagnosis of 
a slowly progressive endogenous endophthalmitis when fungal infection is considered 
likely. (70) Bartonella henselae and Tropheryma whipplei are rare pathogens in humans and 
were recently recognized as important causative agents of culture-negative endocarditis that 
the bacteria are indentified by polymerase chain reaction analysis. (71,72) Exposure to cats is 
an important risk factor for B.henselae which is the causative agent of cat scratch disease 
characterized by persistent regional lymhadenopathy. (73) B. henselae is responsible for 
endocarditis in patients with valvular diseases, and may induce retinitis. (73) Whipple’s 
disease is characterized by wide range of clinical manifestations involving diarrhea, weight 
loss, night sweats, arthritis, vitritis retinitis and papillitis. (74) 
Fungal organisms can occur in up to 50% of all cases of endogenous endophthalmitis. (57) 
Candida albicans is by far the most frequent cause (75-80% of fungal cases). (57) Since 1980, 
candidal infections reported in intravenous drug users have increased. (57) The number of 
people at risk may be increasing because of the spread of AIDS, more frequent use of 
immunosuppressive agents, and more invasive procedures. (57,75) The classic finding of 
Candida endophthalmitis is white chorioretinal infiltrates with fluffy white vitreous 
opacities described as “string of pearls” appearance. (76,77) The chorioretinitis may progress 
and satellite lesions may develop adjacent to the primary lesions. (77) Occasionally anterior 
uveitis, scleritis and panophthalmitis may also occur. (77) Aspergillus endogenous 
endophthalmitis, although less common, is frequently a more fulminent disease. (76) It has a 
predilection for the postequatorial fundus. (78) A confluent yellowish infiltrate is usually 
seen in the macula beginning in the choroid or subretinal space. (78) Histologically, the 
retinal and choroidal lesions are angiocentric. (76) Unlike candida endophthalmitis, in 
which the vitreous is the primary focus of infection, aspergillus endophthalmitis is marked 
by retinal and choroidal vessel invasion and subretinal pigment epithelial and subretinal 
infection. (76) The lesions can progress to retinal vascular occlusion and full-thickness 
retinal necrosis. (78) Intraretinal hemorrhages usually occur. (78) Eventually the infection  
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spreads into the vitreous, producing dense vitritis, and into the anterior segment, producing 
varying degrees of cell/flare and hypopyon in the anterior chamber. (76,78) The macular 
lesions heal to form a central atrophic scar. (78) Endogenous cryptococcal endophthalmitis 
has nonspecific ocular inflammatory signs including intraretinal hemorrhage, vascular 
sheathing, yellow-white chorioretinal mass or scarlike lesion. (79,80) Retinal detachment 
may complicate the infection. (79) The infection is usually misdiagnosed as sterile uveitis. 
(79) Suspicion of infection should be greater in the presence of a yellow or white 
chorioretinal abscess. (79,80) Coccidioidal endophthalmitis is an uncommon presentation in 
patients with disseminated disease. (81) Usually a severe granulomatous iridocyclitis 
characterized by mutton- fat keratic precipitates is present. (81) Multifocal choroiditis, 
typified by several, scattered, discrete yellow-white lesions measuring less than the disc 
diameter in size, is observed. (81) Occasionally, vascular sheathing, vitreous haze, serous 
retinal detachment and retinal hemorrhage may also be seen. (81) Less commonly, 
Histoplasma capsulatum and other dimorphic fungi have been implicated in endogenous 
endophthalmitis. (57) Endogenous histoplasmic endophthalmitis has been reported in 
several patients with disseminated systemic histoplasmosis. (82) The ocular infection may 
result in a granulomatous anterior uveitis. (82) Vitritis may be mild to severe. (82) The 
classic fundus lesion is a cream-colored or gray-white chorioretinal infiltrate, often 
surrounded by hemorrhage. (82) There may be associated retinal pigment epithelial 
alteration, indicating partial spontaneous healing. (82) The lesions may be solitary or 
multiple can range from less than a disc diameter to several disc diameters. (83) 
Histoplasmic optic neuritis has also been reported in association with the chorioretinitis. (83) 
The ocular findings are not specific for histoplasmic endophthalmitis, and the diagnosis 
should be suspected in any immunosuppressed patient living in an area endemic for 
histoplasmosis. (83) Rare causes of endogenous fungal endophthalmitis include Fusarium 
species, Mucormycosis, Paecilomyces species, Pencillium species, Bipolaris hawaiiensis, and 
Trichosporon beigelii. (84,85) Endophthalmitis due to systemic fungaemia is less commonly 
reported in East Asian countries. (57) 
8. Diagnosis 
The high incidence of misdiagnosis of endogenous endophthalmitis ranging from 
conjunctivitis, acute glaucoma or other ocular conditions should alert the ophthalmologist to 
make a correct diagnosis of this insidious entity. The possibility of endogenous 
endophthalmitis should be considered in any patient who manifests a pronounced anterior 
reaction that is refractory to steroid treatment. The appropriate diagnosis is necessary to 
start the appropriate treatment and influence dramatically the visual outcome as well as 
reduce the incidence of systemic complications, sometime fatal. Therefore the crucial point 
is diagnostic suspicion. The diagnostic algorithm should include accurate ocular and 
systemic history, investigation of risk factors, search source of infection, fluorescein 
angiography, (Fig. 12) B/A scan ocular ultrasonography, (Fig. 13) and computerized 
tomography of the orbit (Fig. 14) to exclude posterior involvement, and during the follow-
up to monitor the adequacy of treatment, anterior aqueous tap, vitreous tap or vitrectomy, 
gram stain and culture of ocular and non-ocular fluids including blood, urine, cerebrospinal 
fluid. Organisms are cultured from ocular fluid in 36-73% of cases. (50) In many cases, prior 
treatment for systemic infection with intravenous antibiotics had already been instituted 
and this would reduce the culture positive rate from ocular fluids. A second factor resulting  
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Fig. 12. Fluorescein angiography showing the areas of vascular leakage (hyperfluorescent) 
and the areas of retinal hemorrhage (hypofluorescent) 
 
Fig. 13. B-Scan ultrasonography of the eye showing scleral thickening and dense vitreous 
inflammatory opacifications 
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in a negative culture is sampling from an inappropriate compartment within the eye. Both 
aqueous and vitreous cultures should be obtained unless the organism has been identified 
from a non-ocular source. Beyond an initial diagnostic aqueous and vitreous tap, a pars 
plana vitrectomy can provide additional material for culture. It should be inoculated in 
blood agar, chocolate agar, brain-heart infusion broth/agar, thioglycollate broth and 
Sabouraud agar. (50) A specimen sent for Gram stain may allow provisional categorization 
of the organism. Polymerase chain reaction (PCR) may allow rapid identification of 
organism with high sensitivity, but specificity may be a problem and facilitates for this test 
are not widely available. (50) In comparison with bacterial endogenous endophthalmitis, 
those case caused by fungi rarely have a positive blood culture. (86) Systemic fungaemia is 
either transient or not recognized prior to eye infection. (47) On the other hand, screening of 
several series of patients with candidaemia has not revealed any cases of endophthalmitis. 
(47) The benefit of screening lucid, asymptomatic patients thus remains doubtful at this 
point of time. (47,50) However, vitreous cultures will often reveal the offending organisms 
in these cases. (86) Vitrectomy samples are more sensitive for fungal cultures than vitreous 
needle biopsies. (86) The cultures must be kept at the laboratory for at least 4-6 weeks to 
ensure that slow-growing or fastidious fungal organisms are not missed. (86) PCR is also 
used as a diagnostic tool for fungal endophthalmitis. (87,88) The main advantage of PCR 
over conventional fungal cultures are the higher sensitivity and the rapid results. (87,88) 
Although PCR does not replace conventional mycologic methods, it helps to make an early 
differentiation between bacterial endophthalmitis and fungal endophthalmitis. (88) Candida 
species grow well on Sabouraud media without cycloheximide. (89) The colonies are white 
and pasty. (89) Aspergilli species are observed best with Grocott Methenamine Silver (GMS) 
or Periodic acid-Schiff (PAS) stains. (90) Aspergilli cultures are initially flat, white and 
filamentous. (90) Within 48 hours, conidia are produced with a concomitant change in  
 
Fig. 14. Orbital tomography showing proptosis, extraocular muscle enlargement, soft tissue 
swelling and retrobulbar fat stranding of the left eye 
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pigmentation. (90) Cryptococci also grow well in Sabouraud agar. (91) It may be identified 
by India ink. (91) Coccidioidomycosis can be diagnosed using a 10% KOH mount and 
identifying endospores that contain spherules. (92) 
Apart from microbiological investigation, other tests may be required according to the 
clinical picture. These would include complete blood cell count with differential, erythrocyte 
sedimentation rate, blood urea nitrogen and creatinine.  
8.1 Differential diagnosis 
Endogenous endophthalmitis should always be considered early in the differential 
diagnosis of anterior uveitis. (87) The common causes of anterior uveitis must be excluded 
by the usual serological tests. (87) Glaucoma, CMV retinitis, toxoplasma chorioretinitis, 
primary intraocular lymphoma, syphilitic chorioretinitis, autoimmune causes, malignancies, 
masquerade, metastatic tumors, and other infectious diseases should also be ruled out. (93) 
Rarely, cavernous sinus thrombosis, corneal abrasion, corneal laceration, corneal ulceration 
and ulcerative keratitis, globe rupture, herpes zoster ophthalmicus and vitreous hemorrhage 
are included in the differential diagnosis. (78,94) 
9. Medical treatment 
9.1 Systemic therapy 
Prompt administration of antibiotic therapy is the key in the acute management of 
endogenous endophthalmitis. Systemic antibiotics also treat distant foci of infection and 
prevent continued bacteremia, thereby reducing the chances of invasion of the unaffected 
eye. Prolonged intravenous therapy is usually required for 2-4 weeks, until it is certain that 
the systemic infection is eradicated. (33) Empiric broad-spectrum antibiotic therapy with 
vancomycin and aminoglycoside or a third-generation cephalosporin is recommended at the 
highest theurapeutic doses. (33,52) Gentamycine has the coverage of gram-negative 
organisms including Pseudomonas aeruginosa. (25,44) It is the first choice aminoglycoside 
for systemic gram-negative coverage. (25,44) It has bacteriocidal activity by binding to 30S 
ribosomal subunit and inhibiting protein synthesis. (44) Ceftazidime is the third-generation 
cephalosporin with broad gram-negative coverage but decreased efficacy to gram-positive 
organisms. (95,96) It binds to one or more of the penicillin-binding proteins and prevent cell 
wall synthesis inhibiting bacterial growth. (95) Ceftriaxone is another third-generation 
cephalosporin is active against the resistant gram-negative organisms. (12) For Gram-
positive cover, intravenous vancomycin is warranted in the view of the potential severity of 
the disease and consequences. (95,96) Good Gram-negative coverage is provided by third-
generation cephalosporins, ciprofloxacin and aminoglycosides. (25,44) Although intravenous 
antibiotics can reach therapeutic concentrations in affected eyes, the use of systemic 
antibiotics that have good intraocular penetration and bioavailability is preferred. (97,98) In 
particular, aminoglycosides do not have good intraocular bioavailability when given 
intravenously. (44) In specific situations, certain antibiotics should be preferred. For example, 
bacillus infections mandate the initial use of either vancomycin or clindamycin. (41) In cases 
of fungal sepsis and endophthalmitis amphotericin B provides good efficacy and broad 
coverage. (99,100) It is fungostatic or fungocidal depending on concentration attained in 
body fluids. (101) It is an polyene antibiotic and it changes permeability of fungal  
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cell membrane by binding to sterols, which causes fungal cell death as intracellular 
components leak out. (101) Treatment duration and total dose of intravenous drug are 
determined by the clinical response and the degree of systemic or non-ocular involvement. 
(102) Toxic side effects including renal and hepatic toxicity must be carefully monitored. 
(102) The penetration of amphotericin B into vitreous cavity is poor. (103) Doses of 5-10 
microgram of intravitreal amphotericin is used for treatment. (103) However, retinal 
toxicities have also been reported in animal models at these doses. (103) The azole 
antibiotics are less toxic and have better ocular penetration. (104) Fluconazole and 
flucytosine have good intraocular penetration, but Candida species show high resitance to 
flucytosine. (104) Flucytosine can be used in combination with amphotericin B in cases of 
macular involvement and extensive inflammatory response. (100,104) Itraconazole is useful 
in Aspergillus and Fusarium infections. (99) A new systemic voriconazole, when 
administered orally or intravenously, it has good intravitreal concentrations. (100) 
Intravitreal administration of voriconazole is also safe without evidence of retinal toxicity 
with concentrations up to 25 microgram/ml. (105) The echinocandins (caspofungin, 
micafungin, and anidulafungin) are newer agents that exert their antifungal activity by 
binding D-glucan synthase, an enzyme involved in fungal cell wall synthesis. (106,107) 
Because mammalian cells lack a cell wall, it also represents an ideal and specific target for 
antifungal therapy. (106) Echinocandins exert antifungal activity against Candida and 
Aspergillus species. (106,107) However, they have limited penetration into the vitreous 
cavity so their role in the treatment of fungal endophthalmitis needs to be determined. 
(107) 
9.2 Intravitreal therapy 
Although the value of intravitreal antibiotics over and above the use of intravenous 
antibiotics has not been definitively established, most cases in our experience are of 
posterior diffuse disease and panophthalmitis which denote severe infection with extension 
of organisms into the vitreous. These cases should be treated aggressively as possible with 
both systemic and intravitreal antibiotics. In cases caused by bacteria, intravitreal injection 
of vancomycin 1mg/0.1ml and ceftazidime 2mg/0.1 ml provides good coverage and avoids 
the toxicity associated with aminoglycosides. (41,108) Repeated injections may be required 
since the half-life of these drugs in the vitreous cavity is short. (108) In most cases of fungal 
endophthalmitis, an intravitreal injection of 5-10 microgram amphotericin B is 
recommended. (103) Using amphotericin B in this manner avoids its numerous systemic 
side effects, but its potential for retinal toxicity should be noted. (103) The use of intravitreal, 
topical and subtenon steroids should be avoided in fungal endophthalmitis. (99) However, 
the use of intravitreal steroid, dexamethasone in addition to intravitreal antibiotics is 
recommended for suppression of inflammatory mediators released in the vitreous in 
bacterial endophthalmitis. (108-111) The histopathological changes of the eyes treated with 
intravitreal vancomycin with dexamethasone (0.4 mg/ml) had less conjunctival 
inflammation, mild iridocyclitis, less vitreous cells, less choroidal vasculitis and retinitis 
compared to antibiotic treatment alone. (109,110)  
Topical steroids are also used in patients with anterior focal or diffuse endophthalmitis to 
reduce the number of inflammatory cells in the anterior chamber, thereby preventing the 
complications such as formation of synechiae and secondary glaucoma. (112-114) 
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Topical antibiotics are definitively indicated if keratitis develops and adjunctive therapy 
includes the use of cycloplegics, ocular hypotensives and topical steroids. (113,114) 
9.3 Surgical treatment 
The timing of and necessity for vitrectomy remains unclear in endogenous endophthalmitis. 
(115,116) The benefits of vitreous tap outweigh the benefits of vitrectomy for anterior focal 
or diffuse and posterior focal cases with endogenous endophthalmitis. (38) In general 
vitrectomy is indicated in cases of posterior diffuse cases with prominent vitreous 
involvement, and also for cases showing progressive disease despite intensive medical 
therapy. (116) In these cases small gauge vitrectomy is effective in clearing the vitreous from 
the inflammatory debris, cells and mediators. (117) Other advantage includes the possibility 
to have larger sample to make the diagnosis and also to deliver a therapeutic level of drug in 
the vitreous. (118,119) In these cases vitrectomy and intravitreal antibiotics may, however, 
prevent ocular atrophy or the necessity for enucleation. (119) 
10. Prognosis 
The visual outcome is usually good in the anterior form of endophthalmitis, differently from 
posterior diffuse and panophthalmitis forms. (19) The outcome of posterior diffuse 
endophthalmitis or panophthalmitis is frequently blindness, regardless of the treatment 
measures. (19) In a recent study surveying cases in Singapore over a 4-year period, 17 of 32 
affected eyes ended up with no light perception. (4) In only 40% of patients with 
endogenous endophthalmitis vision is preserved with ability to count fingers or better. (4) 
The virulence factor of the organism and age of the patient are important factors predicting 
outcome. (4,5) Other variables resulting in poorer outcome include severity of underlying 
systemic illness, misdiagnosis or delay in diagnosis, and inappropriate, inadequate or 
delayed treatment, low intraocular pressure, initial visual acuity of light perception, severe 
hypopyon and absent red reflex. (5,6) Ultrasonography negative prognostic factors are 
vitreous and subhyaloid opacities, choroidal and retinal detachments. (35) In general Gram-
positive infections involving microbes such as Staphylococcus and Streptococcus species 
result in a better outcome. (112,120) However, Bacillus infections are typically rapidly 
progressive with a poorer prognosis. (120) Gram-negative organisms, including Klebsiella 
pneumonia, E. coli, P aeruginosa, often result in severe infection and a very poor prognosis. 
(6,12) Exceptions include Haemophilus and Neisseria, but these are uncommon causes of 
endogenous endophthalmitis. (121,122) Fungal endogenous endophthalmitis usually result 
in very poor outcomes, but those caused by Candida species can often be treated effectively 
if early and appropriate antifungals are used. (98,99) 
11. Conclusion 
Endogenous endophthalmitis continues to occur among the patients with infective 
endocarditis despite the continuing development of effective antibiotics. Although it is 
devastating, vision can sometimes be salvaged, especially if diagnosis is made early and 
prompt systemic therapy instituted. The role of intravitreal antibiotics and vitrectomy is not 
well defined but they have a definite role in cases which progress despite medical therapy 
and also where fungi are implicated. Future challenge ahead include the aging population 
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and the development of new microbial antibiotic resistance. A coordinated multidisciplinary 
effort will be required to keep abreast of this difficult condition. 
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